Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4029075011 | Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4029076012 | Belantamab mafodotin only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Is a | Belantamab mafodotin only product | true | Inferred relationship | Some | ||
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Is a | Product containing belantamab mafodotin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) | Has active ingredient | Belantamab mafodotin | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets